Why Lexeo Therapeutics, Inc.’s (LXEO) Stock Is Up 6.44%
As of Friday, November 20, Lexeo Therapeutics, Inc.’s LXEO share price has surged by 6.44%, which has investors questioning if this is right time to sell.Tudor Pop
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Tudor Pop
Tudor Pop
Jenna Brashear
Jenna Brashear
Jenna Brashear
| Share Statistics | LXEO | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $245.5 | $203.5 | 31% |
|
| Shares Out (Mil) | 88.7 | 55.2 | 59% |
|
| Institutional Ownership | 99.5% | 93.3% | 89% |
|
| Float (Mil) | 50.5 | 40.4 | 46% |
|
| Beta | 1.65 | 1.05 | 86% |
|
| Avg Daily Volume (000s) | 5,141 | 569 | 92% |
|
| Price Change (52-week) |
(67.4%) | 38.8% | 14% |
|
| Growth | LXEO | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 13.6% | na |
|
| Net Income (5yr) | (80.6%) | (10.7%) | 3% |
|
| EPS (5yr) | 12.2% | 15.4% | 51 |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | (51.9%) | (15.7%) | 6% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 7 | 6 | 7 | |
| Current EPS | ($0.354) | ($1.338) | ($1.481) | |
| Month Ago EPS | ($0.331) | ($1.199) | ($1.364) | |
| # Rev Up | 0 | 0 | 0 | |
| # Rev Down | 1 | 1 | 1 | |
| Three Months Ago EPS | ($0.331) | ($1.199) | ($1.369) | |
| Year/Year Chg | (18.1%) | (28.2%) | (14.8%) | |
| Financials | LXEO | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $40 | na |
|
| Net Income (TTM) (Mil) | ($105) | ($44) | 11% |
|
| EPS (TTM) | ($1.268) | ($1.400) | 18% |
|
| Operating Cash Flow (TTM) (Mil) | ($87) | ($35) | 7% |
|
| Net Cash Flow (TTM) (Mil) | $49 | $-0 | 70% |
|
| Long-Term Debt (Q1) (Mil) | $4 | $4 | 23% |
|
| Enterprise Value (Q1) (Mil) | $79 | $142 | 20% |
|
| Valuation | LXEO | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.13 | 1.96 | 34% |
|
| P/E | na | 16.9 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 0.9 | na |
|
| Ratios | LXEO | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 67.6% | na |
|
| Net Margin | na | (50.8%) | na |
|
| ROA | (54.3%) | (47.0%) | 10% |
|
| ROE | (62.4%) | (51.8%) | 13% |
|
| Liabilities to Assets | 11.2% | 29.6% | 7% |
|
| F-Score | 4 | 3 | 33% |
|
Passing Stock Screens
As of 11/20/2026, from a list of 60 stock screening strategies,
| Performance Since Inception: | 2.1% |
| +/- S&P 500: | -5.3 |
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors